← Companies
BIODESIX INC
Data as of Oct 14, 2026
Reported federal lobbying
$210K
7 filings · latest Jul 20, 2026
Federal contracts since 2024
$844K
7 awards · latest Jun 3, 2026
Lobbying
$210,000 in reported federal lobbying spend across 7 quarterly filings, most recently Jul 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.
Spend by issue
- Medicare/Medicaid +1$180K6 filings
- Health Issues +1$30K1 filing
Latest filings, Apr 2025 onward
| Filed | Registrant and subject | Amount |
|---|---|---|
| Jul 20, 2026 | TODD STRATEGY GROUP for BIODESIX INC. Medicare/Medicaid · Health Issues Medicare reimbursement for diagnostics. Medicare Contractor Reform.
Lab test regulatory and reimbursement reform. | $30,000 |
| Apr 20, 2026 | TODD STRATEGY GROUP for BIODESIX INC. Medicare/Medicaid · Health Issues Medicare reimbursement for diagnostics. Medicare Contractor Reform.
Lab test regulatory and reimbursement reform. | $30,000 |
| Jan 20, 2026 | TODD STRATEGY GROUP for BIODESIX INC. Medicare/Medicaid · Health Issues Medicare reimbursement for diagnostics. Medicare Contractor Reform.
Lab test regulatory and reimbursement reform. | $30,000 |
| Oct 11, 2025 | TODD STRATEGY GROUP for BIODESIX INC. Medicare/Medicaid · Health Issues Medicare reimbursement for diagnostics. Medicare Contractor Reform.
Lab test regulatory and reimbursement reform. | $30,000 |
| Jul 19, 2025 | TODD STRATEGY GROUP for BIODESIX INC. Medicare/Medicaid · Health Issues Medicare reimbursement for diagnostics. Medicare Contractor Reform.
Lab test regulatory and reimbursement reform. | $30,000 |
| Apr 21, 2025 | TODD STRATEGY GROUP for BIODESIX INC. Medicare/Medicaid · Health Issues Medicare reimbursement for diagnostics. Medicare Contractor Reform.
Lab test regulatory and reimbursement reform. | $30,000 |